Evidence map›Paper›PMID 38272895›Full record

ArticleNature communications2024

A multiplexed, confinable CRISPR/Cas9 gene drive can propagate in caged Aedes aegypti populations.

Michelle A E Anderson, Estela Gonzalez, Matthew P Edgington, Joshua X D Ang, Deepak-Kumar Purusothaman, Lewis Shackleford, Katherine Nevard, Sebald A N Verkuijl, Timothy Harvey-Samuel, Philip T Leftwich and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Modeling Control of Invasive Fire Ants by Gene Drive.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Michelle A E Anderson *Arthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK.ORCID 0000-0003-1510-2942
Estela Gonzalez *Arthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK.ORCID 0000-0002-4296-0080
Matthew P EdgingtonArthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK.ORCID 0000-0003-1922-9529
Joshua X D AngArthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK.
Deepak-Kumar PurusothamanArthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK.ORCID 0000-0003-4827-6519
Lewis ShacklefordArthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK.
Katherine NevardArthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK.ORCID 0000-0002-1008-6587
Sebald A N VerkuijlArthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK.ORCID 0000-0002-6771-0280
Timothy Harvey-SamuelArthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK.
Philip T LeftwichArthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK.ORCID 0000-0001-9500-6592
Kevin EsveltMedia Laboratory, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Luke AlpheyArthropod Genetics, The Pirbright Institute, Ash Road, Pirbright, GU24 0HN, UK. luke.alphey@york.ac.uk.ORCID 0000-0002-2916-3802
The Pirbright Institute · GBMassachusetts Institute of Technology · USUniversity of East Anglia · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00007033Biotechnology and Biological Sciences Research Council BBS/E/I/00007038Biotechnology and Biological Sciences Research Council BBS/E/I/00007039Wellcome TrustWellcome Trust 110117/Z/15/Z
6 · The paper itself

Abstract

Aedes aegypti is the main vector of several major pathogens including dengue, Zika and chikungunya viruses. Classical mosquito control strategies utilizing insecticides are threatened by rising resistance. This has stimulated interest in new genetic systems such as gene drivesHere, we test the regulatory sequences from the Ae. aegypti benign gonial cell neoplasm (bgcn) homolog to express Cas9 and a separate multiplexing sgRNA-expressing cassette inserted into the Ae. aegypti kynurenine 3-monooxygenase (kmo) gene. When combined, these two elements provide highly effective germline cutting at the kmo locus and act as a gene drive. Our target genetic element drives through a cage trial population such that carrier frequency of the element increases from 50% to up to 89% of the population despite significant fitness costs to kmo insertions. Deep sequencing suggests that the multiplexing design could mitigate resistance allele formation in our gene drive system.

Indexed as

AedesGene Drive TechnologyInsecticidesZika VirusZika Virus InfectionAnimalsCRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsInsecticidesRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID38272895
PMCPMC10810878
OpenAlexW4391229152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.